Use when packaging AAAI code, data, multimedia appendices, technical appendices, reproducibility evidence, and post-acceptance artifact releases without violating double-blind or immutable-supplement rules.
日本語の概要は準備中です。原文の説明を表示しています。
Use when building or revising exhibits for an AEJ: Economic Policy manuscript so they meet AEA house style and carry the policy message — no significance asterisks, a self-contained headline exhibit, and figures that show the policy effect with uncertainty. Designs exhibits; it does not run the estimation or write the surrounding prose.
インストールする前に、エージェントに与えられる指示の中身を確認できます。
Every AEJ: Policy paper should have one exhibit a policymaker could screenshot: the policy effect in interpretable units with its welfare/cost-benefit reading where possible. Examples (illustrative formats):
esttab/booktabs), no vertical rules; align decimals; consistent digits.Generate exhibits from the fitted result, not by retyping numbers (the usual source of
body-vs-appendix drift). Full map: execution-with-mcp.
etable (multi-model columns) or did_summary_to_latex straight from the
result_id — one variable definition, one set of numbers, body and appendix in sync.plot_from_result / enhanced_event_study_plot / event_study_table —
axis units and the SE/clustering note baked in.See a full fitted-result → exhibit chain in the JF execution walkthrough.
| Design | Workhorse figure | What the notes must state |
|---|---|---|
| DID / event study | Event-study coefficients with CI bands; flat pre-period leads visible | estimator (CS/SA), comparison group, clustering level |
| RDD | Binned means + fitted discontinuity + bandwidth | running variable, bandwidth, density-test result |
| Bunching | Empirical vs. counterfactual density at the kink | counterfactual construction, excluded region |
| RCT | Treatment-control means / dose-response with CIs | randomization unit, take-up, ITT vs. ToT |
| Welfare | MVPF / cost-per-outcome across variants, with bands | which estimates feed the ledger, assumptions |
A tax-credit paper's main table reports a coefficient of 0.08 (s.e. 0.02) on the credit. Reworked for AEJ: Policy: the lead exhibit becomes a figure of employment around the credit's introduction with a CI band, the long-run effect annotated as "+3.1 pp employment (90% CI [1.9, 4.3])," and a companion row translating it into cost per additional job with its band — the number a policymaker takes away. No asterisks; SEs in parentheses throughout.
【Headline exhibit】figure/table + the policy magnitude it carries
【Significance reporting】SEs/CIs, no asterisks? [Y/N]
【Self-contained notes】sample/units/estimator/clustering/N/dep-mean present? [Y/N]
【Policy-units translation】coefficient → cost-per-X / MVPF / incidence shown? [Y/N]
【Next step】aejpol-writing-style
まだレビューはありません。使ってみた感想をお寄せください。
概要と使いどころ
Use when packaging AAAI code, data, multimedia appendices, technical appendices, reproducibility evidence, and post-acceptance artifact releases without violating double-blind or immutable-supplement rules.
日本語の概要は準備中です。原文の説明を表示しています。
Use when drafting an AAAI author response (rebuttal) under the single short character-limited author-feedback window, the no-URL rule, no-new-results guidance, AI-generated-review handling, and the AAAI two-phase review process where Phase-2 papers receive one feedback round before SPC/AC discussion.
日本語の概要は準備中です。原文の説明を表示しています。
Use when preparing an accepted AAAI paper for camera-ready source submission to AAAI Press, including proceedings page limits, two-column template compliance, copyright transfer, purchased extra technical pages, deanonymization, registration, oral or poster presentation, and final public artifact release.
日本語の概要は準備中です。原文の説明を表示しています。
Use when designing or auditing AAAI experiments for the broad-AI program committee, including baselines, ablations, statistical significance, robustness, human evaluation, AI-for-Social-Impact and alignment/safety evidence, compute and cost reporting, and reproducibility-checklist alignment for Phase-1 survival.
日本語の概要は準備中です。原文の説明を表示しています。
Use when positioning an AAAI paper's novelty against archival work, contemporaneous arXiv or workshop papers, and AAAI/IJCAI/NeurIPS/ICML/ICLR neighbors across the broad AI scope, while staying inside AAAI's dual-submission and AI-as-source policy constraints and writing a related-work section legible to non-specialist reviewers.
日本語の概要は準備中です。原文の説明を表示しています。
Use when strengthening an AAAI paper's reproducibility checklist (placed after references), experimental traceability, seed and hyperparameter reporting, compute and cost disclosure, dataset access and licensing, code/data ZIP readiness, and the claim-to-evidence map that Phase-1 reviewers use to judge rigor across AAAI's broad AI scope.
日本語の概要は準備中です。原文の説明を表示しています。